GGrantIndex
Sort

50,496 grants matching lung cancer

Novel therapy targeting refractory colon cancer

$454,126
Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA

Improving pathologic nodal staging of resected lung cancer

$454,098
Raymond U Osarogiagbon · Baptist Memorial Hospital - Tipton · R01 · FY2019 · CA

Interaction of histamine-releasing factor with immunoglobulins in asthma

$454,098
Toshiaki Kawakami · La Jolla Institute For Immunology · R01 · FY2016 · HL

Deregulation of long noncoding RNAs in cancer

$454,095
Nadya M Dimitrova · Yale University · R01 · FY2024 · CA

Examining nicotine relapse in the habenulo-interpeduncular system

$454,086
Ryan Michael Drenan · Wake Forest University Health Sciences · R01 · FY2022 · DA

Examining nicotine relapse in the habenulo-interpeduncular system

$454,086
Ryan Michael Drenan · Wake Forest University Health Sciences · R01 · FY2023 · DA

Examining nicotine relapse in the habenulo-interpeduncular system

$454,086
Ryan Michael Drenan · Wake Forest University Health Sciences · R01 · FY2024 · DA

Examining nicotine relapse in the habenulo-interpeduncular system

$454,086
Ryan Michael Drenan · Wake Forest University Health Sciences · R01 · FY2025 · DA

Metabolic Studies of Mouse Models of Obesity and Diabetes

$454,080
Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2015 · DK

A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS

$454,077
Kent Rossman · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA

Vanderbilt Clinical Oncology Research Career Development Award

$454,075
Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2016 · CA

Tumor Cell Dependence on Host Metabolism

$454,038
Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA

BIOMAKERS IN LUNG CARCINOMA AND PREMALIGNACY

$454,017
University Of Colorado Denver · U01 · FY2001 · CA

Exosome secretion in breast cancer progression

$453,988
Alissa M Weaver · Vanderbilt University · R01 · FY2025 · CA

Persistent transcriptional changes induced by nickel through epigenetic alterations

$453,988
Suresh Cuddapah · New York University School Of Medicine · R01 · FY2020 · ES

Targeting glycocalyx-mediated mechanisms of tumor metastasis

$453,981
Lance L Munn · Massachusetts General Hospital · R01 · FY2020 · CA

Targeting glycocalyx-mediated mechanisms of tumor metastasis

$453,981
Lance L Munn · Massachusetts General Hospital · R01 · FY2021 · CA

Proteomic determinants of response to checkpoint blockade in malignant pleuralmesothelioma

$453,938
Bryan Michael Burt · Baylor College Of Medicine · R37 · FY2021 · CA

Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma

$453,875
Markus Schober · New York University School Of Medicine · R01 · FY2021 · CA

Epigenetic Therapy for Thoracic Malignancies

$453,874
David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA

Identifying intercellular circuits driving cell phenotypes within a niche

$453,870
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer

$453,869
Phillip A Sharp · Massachusetts Institute Of Technology · R01 · FY2014 · CA

Lung cancer heterogeneity and its impact on drug resistance.

$453,829
Steven J Altschuler · Ut Southwestern Medical Center · R01 · FY2012 · CA

Confocal Core for the Laboratory of Cellular and Molecular Biology

$453,805
Valarie Barr · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

3-Methylindole-Induced Lung Injury

$453,800
Garold S Yost · University Of Utah · R01 · FY2006 · HL